Frank Lambertus1, Christoph Herrmann-Lingen2, Kurt Fritzsche3, Stefanie Hamacher4, Martin Hellmich4, Jana Jünger5, Karl-Heinz Ladwig6, Matthias Michal7, Joram Ronel8, Jobst-Hendrik Schultz5, Frank Vitinius1, Cora Weber9, Christian Albus10. 1. Dept. of Psychosomatics and Psychotherapy, University of Cologne, Germany. 2. Dept. of Psychosomatic Medicine and Psychotherapy, University of Goettingen Medical Center, Germany; German Center for Cardiovascular Research (DZHK), partnersite Göttingen, Germany. 3. Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital of Freiburg, Germany. 4. Institute of Medical Statistics, Informatics and Epidemiology, University of Cologne, Germany. 5. Dept. of General Internal and Psychosomatic Medicine, University of Heidelberg, Germany. 6. Institute of Epidemiology, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health, Germany. 7. Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital of Mainz, Germany. 8. Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Rechts der Isar, Technische Universitaet Muenchen, Germany. 9. Dept. of Psychosomatics and Psychotherapy, Charité Universitaetsmedizin Berlin, Campus Benjamin Franklin, Germany. 10. Dept. of Psychosomatics and Psychotherapy, University of Cologne, Germany. Electronic address: christian.albus@uk-koeln.de.
Abstract
OBJECTIVE: Type D personality, as with formal mental disorders, is linked to increased mortality in coronary heart disease (CHD). Our aim was to determine the prevalence of mental disorders among depressed CHD patients with and without Type D personality. METHODS: Depressive symptoms (HADS, HAM-D), Type D personality (DS-14) and mental disorders based on DSM-IV (SCID I and II) were assessed. Results were calculated by Kruskal-Wallis tests, Fisher's exact tests and logistic regression analyses. RESULTS: 570 CHD patients were included (age 59.2±9.5years; male 78.9%, HADS-D depression 10.4±2.5; HAM-D 11.3±6.6; Type D 60.1%). 84.8% of patients with Type D personality and 79.3% of non-Type D patients suffered from at least one mental disorder (p=0.092), while 41.8% of Type D positives and 27.8% of Type D negatives had at least two mental disorders (p=0.001). Patients with Type D personality significantly more often had social phobia [odds ratio (95% confidence interval): 3.79 (1.1 to 13.12); p=0.035], dysthymia [1.78 (1.12 to 2.84); p=0.015], compulsive [2.25 (1.04 to 4.86); p=0.038] or avoidant [8.95 (2.08 to 38.49); p=0.003] personality disorder. CONCLUSIONS: Type D personality among depressed CHD patients is associated with more complex and enduring mental disorders. This implies higher treatment demands. TRIAL REGISTRATION: ISRCTN 76240576; NCT00705965.
OBJECTIVE: Type D personality, as with formal mental disorders, is linked to increased mortality in coronary heart disease (CHD). Our aim was to determine the prevalence of mental disorders among depressed CHDpatients with and without Type D personality. METHODS:Depressive symptoms (HADS, HAM-D), Type D personality (DS-14) and mental disorders based on DSM-IV (SCID I and II) were assessed. Results were calculated by Kruskal-Wallis tests, Fisher's exact tests and logistic regression analyses. RESULTS: 570 CHD patients were included (age 59.2±9.5years; male 78.9%, HADS-D depression 10.4±2.5; HAM-D 11.3±6.6; Type D 60.1%). 84.8% of patients with Type D personality and 79.3% of non-Type D patients suffered from at least one mental disorder (p=0.092), while 41.8% of Type D positives and 27.8% of Type D negatives had at least two mental disorders (p=0.001). Patients with Type D personality significantly more often had social phobia [odds ratio (95% confidence interval): 3.79 (1.1 to 13.12); p=0.035], dysthymia [1.78 (1.12 to 2.84); p=0.015], compulsive [2.25 (1.04 to 4.86); p=0.038] or avoidant [8.95 (2.08 to 38.49); p=0.003] personality disorder. CONCLUSIONS: Type D personality among depressed CHDpatients is associated with more complex and enduring mental disorders. This implies higher treatment demands. TRIAL REGISTRATION: ISRCTN 76240576; NCT00705965.
Authors: Matthias Vogel; Christian Riediger; Martin Krippl; Jörg Frommer; Christoph Lohmann; Sebastian Illiger Journal: Pain Res Manag Date: 2019-01-03 Impact factor: 3.037
Authors: Ciro Conversano; Laura Marchi; Ciacchini Rebecca; Claudia Carmassi; Bastianina Contena; Laura Maria Bazzichi; Angelo Gemignani Journal: Clin Pract Epidemiol Ment Health Date: 2018-09-28